Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back

<div>Distribution of endometrioma diameter quartiles prior to and after treatment with 3 months of aromatase inhibition plus progestin add-back.</div>

BioMed Research International

fig1

Figure 1

Figure 1: Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back 